Abstract
AbstractTuberculosis (TB) is a potentially fatal infectious disease that, in Aotearoa New Zealand (NZ), inequitably affects Asian, Pacific, Middle Eastern, Latin American, and African (MELAA), and Māori people. Medical research involving genome sequencing of TB samples enables more nuanced understanding of disease strains and their transmission. This could inform highly specific health interventions. However, the collection and management of TB isolate samples for research are currently informed by monocultural biomedical models often lacking key ethical considerations. Drawing on a qualitative kaupapa Māori–consistent study, this paper reports on preliminary discussions with groups of Māori, Pacific, and Afghan people in NZ, whose communities have been harmed by TB and TB stigma. Participants’ discussions highlight key concerns and meanings that ought to inform the development of guidelines and a more robust consultative process for the governance of how TB isolate samples are collected and used both retrospectively and in future research. We argue for ethical processes to be culturally nuanced and community-generated, flexible and meaningful, and situated in relation to the physical and symbolic effects of TB. We discuss the significance of Indigenous data sovereignty, rights, and kāwanatanga (governorship) in shaping a multicultural data sovereignty model.
Funder
Maurice and Phyllis Paykel Trust
University of Auckland
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Anderson, A. 2008a. Mark of shame: Social stigma, tuberculosis and Asian immigrants to New Zealand. In Multiplying and dividing: TB in Canada and Aotearoa New Zealand, edited by J. Park, A. Herring, J. Littleton, and T. Farmer, 196–204. Auckland: University of Auckland.
2. ———. 2008b. Understanding migrants’ primary healthcare utilisation in New Zealand through an ethnographic approach. Diversity in Health and Social Care 5(4):291–301.
3. Badu, E., C. Mpofu, and P. Farvid. 2018a. Is New Zealand immigration policy a barrier to TB elimination? The New Zealand Medical Journal 131(1477): 120–122.
4. ———. 2018b. Towards TB elimination in Aotearoa/New Zealand: Key informant insights on the determinants of TB among African migrants. Tropical Medicine and Infectious Disease 3(2):44
5. Boulton, A., M. Hudson, A. Ahuriri-Driscoll, and A. Stewart. 2014. Enacting Kaitiakitanga: Challenges and complexities in the governance and ownership of Rongoa research information. International Indigenous Policy Journal 5(2): 1–18.